Steve Haggarty, PhD


Stephen is an Associate Professor of Neurology at Harvard Medical School, an Associate Neuroscientist at Massachusetts General Hospital (MGH), Director of the MGH Chemical Neurobiology Laboratory within the Center for Genomic Medicine and Scientific Director of Neurobiology for the MGH Center for the Neuroscience of Psychedelics. Dr. Haggarty is also a Senior Associate Member of the Broad Institute, an Affiliate Faculty Member of the Harvard Stem Cell Institute, and he was named the Stuart & Suzanne Steele MGH Research Scholar in 2017. Dr. Haggarty completed his PhD in the Department of Chemistry & Chemical Biology at Harvard University, and joined the faculty of Harvard Medical School/MGH in 2006. With a background in the discovery and characterization of natural products and natural product-inspired molecules, Dr. Haggarty’s research program operates at the interface of psychiatry and neurology with a focus on dissecting the role of neuroplasticity and resiliency in health and disease. A major emphasis of his research group is the use of reprogramming technology to create patient-specific, induced pluripotent stem cells (iPSCs) as ex vivo models that provide powerful new avenues for studies of neuroplasticity, to investigate the mechanism of action of existing psychoactive molecules, and in the future to potentially discover next- generation agents with improved efficacy to advance the field of precision medicine.

Scientific Co-Founders


Senior Director, Head of Computational Biology
Research Associate II, Neurobiology
Senior Research Associate, Neuroscience
Chief of Staff and Co-Founder
Senior Research Associate, Neurobiology
CEO and Co-Founder
Director, Neurobiology
Associate Director, Finance
Chief Scientific Officer
Senior Scientist, Computational Biology
Senior Manager, Finance
Scientist I, Computational Biology
Director, Drug Discovery
Vice President, Finance